Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
14£k buy says it’s positive
So would I. Her statement shows no insight into her limitations in this role.
I think 🤔 it’s a positive
Don’t know the cash situation but Suzy knows this has potential and needs some one who knows how to progress and it will
Still not an incentive to buy shares here. The crew are now engaged in rearranging the deck chairs on the Titanic while they discuss who they want to be Captain, assuming they can find a volunteer on what will have to be a pretty low salary. I'll guess some fanfare appointment in a couple of months to support a(nother) raise.
Just more uncertainty while they search for another CEO. By their own admission, that could take months. Is there any danger that this crock will actually ever get some revenue rather than fart around with congratulating each other?
Up or down
Reading her statement anyone would think she'd actually achieved something! A complete disaster and I'll be glad to see to see her gone.
This really should have happened before now. But it takes some bravery to admit she realises that someone else is needed for the next chapter.
Suzy has taken a lot of criticism in recent months, however sensible holders know that her scientific skills and knowledge of the val compounds make her a valuable asset to the company. I hope that Valirx utilise that accordingly.
Experienced at what exactly? Fundraising and sneering at shareholders?
Cox has delivered ZERO value to this business.
You need experience so no choice but to keep him. We have a shareholder on the board and changes as requested.
It is a combination of both experience and shareholder interests which should work. It would have been better had it been Adam before he got turned down.
I won't be buying, not until Dr Cox has gone.
His chairmanship has been disastrous and he's equally culpable, in my view.
I hope Suzy stays in a scientific role.
What a beautiful RNS to wake up to. Well done to all those involved. Suzy’s mistake was to always think she was untouchable. Should of learned from the last 2, but alas, the power and money went to her head. Hopefully we can move on stronger. Nick said he would be in strong if Suzy wasn’t CEO. Let’s see if he has been telling the truth!
Let's see if Pinky and Perky now stay true to their word and buy !
Love to know what her definition of growth is and how her work has improved either the company or sp
Was a failure due to delays but not a failure. All to play and will likely complete very soon and the lab will be a success.
EUDA continues its march to the finishing line. News will come shortly.
'Those suggested to replace no doubt want Suzy to remain as they need someone that can guild them without any experience in this field but somehow it will not work.'
'I would keep Suzy and Kevin until June and bring 1/2 shareholders not more plus one other industry expert so maybe the SAR guy that was suggested.'
'I don't support the proposed changes, It makes no sense to me if you are invested. How can you replace industry experience with 3 individuals that have limited experience.'
This poster must be upset that Suzy is leaving; maybe he will sell up; maybe not - talk is cheap...
Had to happen.
201 - failure
Lab - failure
H
I guess the matter is settled then. NO EGM which is good. Will those larger buyers promising to buy now buy. I suspect not as it is all cheap talk.
Seems the requisition notice worked and was successful in their proposals
Requisition
ValiRx plc (the "Company") (AIM: VAL), a life sciences company focusing on early-stage cancer therapeutics and women's health, provides an update on the planned board restructuring and shareholder requisition.
The Board is commencing an executive search to seek a Chief Executive Officer to lead the next stage of growth of the Company. The Company recognises the highly specialised nature of this role and anticipates the required process to identify the appropriate candidate may take a number of months, during which period Dr Dilly will remain as Chief Executive Officer. As part of the re-structuring process, Dr Dilly and the Board will consider potential alternative roles within the Company or Group.
In addition, Adrian de Courcey will join the ValiRx Board as a proposed Non-Executive Director, subject to completion of regulatory due diligence and Ray Horn will become a Board observer.
The Company announces that the Shareholder Requisition Notice to requisition a General Meeting of the Company, as announced on 4 March 2024, has been withdrawn and a General Meeting will not be convened.
Dr Suzy Dilly commented "I've been honoured to play a leading role in establishing the new preclinically-focussed strategy for ValiRx in the period since my appointment in 2020, and as the Company grows it is appropriate for an individual with experience of leading larger companies is sought to better serve the Company's needs. I remain committed to serving the best interests of our shareholders, our staff and collaborators, and will be available to provide support both to the search and to the integration of the incoming team members."
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR"). The Directors of the Company take responsibility for this announcement
I am sure if new investors were buying here they would be happy with 10p. One can then say they are only about 600% from the highs from 10p.
Not a valid point. EUDA market cap $40 million and rising.
I’m sure American SH will be jumping for joy with the increase to 1.60 USD just another 6 fold increase to go from here to get their money back.
I think the EUDA SP has performed almost as badly as this one, well not quite as bad but certainly in the hall of fame of lost causes
Apparently up 30 % in the last 5 days according to Yahoo Finance.
Clearly something is happening soon.